Emergent BioSolutions Inc. — Director's Dealing 2022

May 31, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2022-05-26

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-26	Common Stock	A	8446	—	Acquired	38052	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.